Related by context. All words. (Click for frequent words.) 78 forodesine 78 phase IIb clinical 77 SUCCEED trial 76 MAGE A3 ASCI 76 metastatic sarcomas 75 Phase #b/#a clinical 75 alvespimycin 75 Allovectin 7 75 ZOLINZA 74 EOquin TM 74 refractory chronic lymphocytic 74 phase IIb trial 74 Phase IIIb clinical 74 Bezielle 74 octreotide implant 74 Ixempra 73 Phase 1b trial 73 BRIM3 73 IMA# 73 ELACYT 73 Aflibercept 73 phase IIb study 73 oral deforolimus 73 MAA submission 73 Azedra 73 metastatic hormone refractory 72 phase IIa clinical 72 HuMax EGFr 72 sorafenib tablets 72 docetaxel Taxotere R 72 Phase Ib study 72 relapsed refractory multiple myeloma 72 OvaRex ® MAb 72 Panzem R NCD 72 BRIM2 72 rALLy clinical trial 72 Xeloda ® 72 EFAPROXYN 72 Amrubicin 72 LymphoStat B TM 72 FOLOTYN ® 72 metastatic castration resistant 72 phase IIb 72 INCB# [001] 72 ongoing Phase 1b 72 Clolar ® 72 Allovectin 7 ® 72 HGS ETR2 72 EDEMA3 72 lintuzumab SGN 72 ruxolitinib 72 Ophena TM 72 assessing T DM1 72 TOCOSOL Paclitaxel 71 PSMA ADC 71 ACTEMRA TM 71 Zenvia ™ 71 CR# vcMMAE 71 lintuzumab 71 Vicinium TM 71 unique alkylating agent 71 deforolimus 71 Cloretazine 71 CRMD# 71 Tarceva TM 71 Phase Ib II 71 OncoVEX GM CSF 71 paclitaxel Taxol ® 71 IIa trial 71 treatment naive genotype 71 registrational trial 71 HGS# 71 oxymorphone ER 71 Phase IIb clinical trials 71 ganetespib 71 custirsen 71 ZACTIMA 71 generation purine nucleoside 71 relapsed multiple myeloma 71 YONDELIS 71 alvimopan 71 axitinib 71 docetaxel Taxotere ® 71 MyVax R 71 Cloretazine ® 71 sunitinib malate 71 registrational 71 LymphoStat B belimumab 71 AVASTIN 71 randomized Phase IIb 71 Phase 2a trial 70 Phase Ib clinical 70 Proxinium TM 70 Cloretazine R VNP#M 70 elotuzumab 70 PANVAC VF 70 evaluating Actimmune 70 CoFactor 70 Quinamed 70 multicenter Phase 70 sNDA submission 70 virus HCV protease inhibitor 70 dirucotide 70 zalutumumab 70 thymalfasin 70 evaluating tivozanib 70 PEG SN# 70 alfa 2a 70 regorafenib 70 metastatic castrate resistant 70 obatoclax 70 omega interferon 70 Fibrillex TM 70 Jevtana 70 tolevamer 70 reslizumab 70 randomized controlled Phase 70 lumiliximab 70 severe hypercholesterolemia 70 treatment naïve genotype 70 Phase Ib IIa 70 antibody MAb 70 Nexavar ® 70 Cimzia TM 70 Allovectin 7 R 70 Pivotal Phase III 70 Torisel 70 metastatic CRC 70 L BLP# 70 UPLYSO 70 Pemetrexed 70 Virulizin ® 70 Glufosfamide 70 omacetaxine mepesuccinate 70 Phase 2b study 70 CTAP# Capsules 70 Urocidin 70 PDX pralatrexate 70 oral prodrug 70 dose escalation clinical 70 acyclovir Lauriad R 70 TLK# 70 phase IIa 70 Pegasys plus Copegus 70 adecatumumab 70 viral kinetic 70 Civacir 70 Onrigin 70 rALLy trial 70 placebo controlled Phase 70 R sorafenib tablets 70 oral rivaroxaban 70 TORISEL 70 Anturol TM 70 BENICAR HCT 70 radiation sensitizer 70 neratinib 69 Vandetanib 69 BRAF inhibitor 69 pertuzumab 69 Tezampanel 69 liposomal formulation 69 ZYBRESTAT 69 Dacogen injection 69 BCIRG 69 sorafenib Nexavar 69 placebo controlled Phase III 69 Seliciclib 69 dose cohort 69 Phase IIb clinical 69 Panzem R 69 CIMZIA TM 69 RANK Ligand inhibitor 69 FOLFOX6 chemotherapy regimen 69 Ketotransdel 69 plus prednisone 69 trastuzumab DM1 T DM1 69 mapatumumab 69 phase IIb III 69 Phase 2b clinical 69 recurrent glioblastoma multiforme 69 aflibercept 69 Targretin capsules 69 XL# SAR# 69 vidofludimus 69 BLA submission 69 zanolimumab 69 Personalized Immunotherapy 69 IL# PE#QQR 69 initiate Phase 1b 69 lexidronam injection 69 Genasense ® 69 ponatinib 69 Viramidine 69 ridaforolimus 69 EOquin 69 tanespimycin 69 Proellex TM 69 investigational immunotherapy 69 Aurexis 69 talactoferrin 69 interferon gamma 1b 69 Phase 2a clinical 69 dasatinib Sprycel ® 69 PROVENGE ® 69 refractory CLL 69 vandetanib 69 Vectibix panitumumab 69 HGS ETR1 69 Daclizumab 69 Traficet EN 69 Phase IIb trials 69 APPRAISE 69 low dose cytarabine 69 trastuzumab Herceptin R 69 Fodosine 69 capecitabine Xeloda 69 eniluracil 69 REVLIMID lenalidomide 69 relapsed MM 69 CLARITY study 69 trastuzumab DM1 69 Zemplar Capsules 69 SinuNase TM 69 mertansine 69 confirmatory clinical 69 phase Ib 69 SPRYCEL ® 69 diabetic neuropathic pain 69 Archexin 69 Revlimid lenalidomide 69 HER2 positive metastatic breast 69 CIMZIA TM certolizumab pegol 69 cetuximab Erbitux 68 PHX# 68 Phase IIa trial 68 BAY #-# 68 Velcade bortezomib 68 pharmacokinetic PK study 68 Phase IIb III 68 Zerenex 68 HCD# [002] 68 APEX PD 68 Phase 1b clinical 68 Fludara ® 68 PROVENGE sipuleucel T 68 LUX Lung 68 Efficacy Results 68 NEBIDO 68 valopicitabine 68 AzaSite Plus 68 orally administered inhibitor 68 EmbraceAC 68 Pivotal Phase 68 Phenoptin 68 paclitaxel Taxol R 68 Cellegesic 68 Ceflatonin 68 Phase 1a clinical 68 refractory multiple myeloma 68 compound INCB# 68 Xelox 68 ACAPODENE 68 TELCYTA 68 DU #b 68 GAMMAGARD 68 ularitide 68 romidepsin 68 Phase Ib 68 Genasense ® oblimersen 68 Phase #b/#a trial 68 non nucleoside inhibitor 68 midstage clinical 68 OPAXIO 68 SNT MC# 68 TO AVOID PREGNANCY WHILE 68 tesmilifene 68 enzastaurin 68 Copegus ribavirin 68 pegylated interferon alpha 68 torezolid phosphate 68 Tanespimycin 68 rindopepimut 68 PNP inhibitor 68 phase 2a 68 intravenous methylnaltrexone 68 metastatic HRPC 68 huC# DM4 68 Omigard 68 HuMax CD4 68 Troxatyl 68 evaluating T DM1 68 Phase IIa trials 68 pivotal Phase III 68 FASLODEX 68 Raptiva ® 68 R lenalidomide 68 FOLFOX6 68 refractory Hodgkin lymphoma 68 MabCampath 68 ANCHOR trial 68 mRCC 68 aflibercept VEGF Trap 68 erlotinib Tarceva ® 68 phase III isavuconazole 68 PrevOnco 68 Phase 1b clinical trials 68 ofatumumab HuMax CD# 68 RELOVAIR ™ 68 PRECISE trial 68 oral methylnaltrexone 68 phase IIIb 68 colesevelam HCl 68 Degarelix 68 OMNARIS HFA 68 baminercept 68 PROMACTA 68 Aptivus ® 68 randomized Phase III 68 ADVANCE PD 68 metastatic pancreatic 68 metastatic colorectal carcinoma 68 vinflunine 68 ThermoDox R 68 Phase 2b Clinical Trial 68 comparator arm 68 ENRICH trial 68 galiximab 68 Annamycin 68 PRT# 68 Elitek 68 teriflunomide 68 dextromethorphan quinidine 68 Bicifadine 68 velafermin belinostat 68 catheter occlusion 68 Contrave# 68 TRISENOX 68 HCV SPRINT 68 telaprevir dosed 68 lesinurad 68 confirmatory Phase III 68 Combination REOLYSIN R 68 MERLIN TIMI 68 Peginterferon alfa 2b 68 orBec 68 GALNS 68 DEB# 68 cancer neuroendocrine tumor 68 ORENCIA ® 68 PREOS 68 Matrix Phase 2b 68 ORENCIA R 68 systemic anaplastic large 68 BLP# Liposome Vaccine 68 PDE4 inhibitor 68 CIMZIA ™ 68 evaluating satraplatin 68 Phase 1b 68 investigational antiplatelet agent 68 dose escalation trial 68 bevacizumab Avastin ® 68 GRNVAC1 68 PI3K/Akt pathway inhibitor 68 anticancer compound 68 Tiuxetan 68 Phase #/#a trial 68 APTIVUS 68 VELCADE melphalan 68 Pazopanib 68 recurrent metastatic ovarian cancer 68 ixabepilone 68 multicenter Phase II 68 Xanafide 68 cetuximab Erbitux R 68 TELINTRA 68 dose escalation Phase 68 GW# [003] 68 opioid induced bowel dysfunction 68 Initiate Phase 68 CAELYX 68 JAK inhibitor 68 Kamada AAT 68 generation Hsp# inhibitor 68 COMFORT II 68 Nexavar sorafenib 68 cangrelor 68 Zybrestat 68 BENLYSTA ® 68 Insegia 68 elacytarabine 68 initiate Phase Ib 68 velafermin 68 AEG# 68 Ocrelizumab 68 elagolix 67 brivaracetam 67 Aloxi injection 67 INSPIRE Trial Phase III 67 ToGA 67 budesonide foam 67 NP2 Enkephalin 67 selective androgen receptor modulator 67 GetGoal Phase III 67 investigational monoclonal antibody 67 standard chemotherapy regimen 67 trastuzumab emtansine T DM1 67 HCV RESPOND 2 67 Gemzar ® 67 DASISION 67 Tocosol Paclitaxel 67 PEARL SC 67 oral FTY# 67 recurrent metastatic 67 ospemifene 67 TAXOTERE R 67 oxaliplatin Eloxatin 67 Achieves Primary Endpoint 67 sipuleucel T 67 GLPG# 67 PLK1 SNALP 67 Phase III clinical 67 CYT# potent vascular disrupting 67 Dabigatran etexilate 67 Pertuzumab 67 Zorbtive TM 67 bendamustine 67 recurrent NSCLC 67 dacetuzumab 67 KRN# 67 Solazed 67 GOUT 67 PREZISTA r 67 Golimumab 67 TYGACIL 67 pradefovir 67 temsirolimus 67 AVONEX ® 67 Aclidinium 67 IRX 2 67 Syncria 67 lapatinib Tykerb 67 TBC# 67 Prestara 67 Afatinib 67 successfully commercialize Iluvien 67 lenalidomide Revlimid R 67 previously untreated follicular 67 severe gastroparesis 67 gemcitabine cisplatin 67 metaglidasen 67 ENDEAVOR III 67 TYKERB 67 thalidomide Thalomid 67 MYDICAR ® 67 BLA filing 67 PRECISE Trial 67 TTF Therapy 67 PEGINTRON TM 67 Irinotecan 67 IoGen 67 Corlux 67 IMC #B 67 novel VDA molecule 67 including eniluracil ADH 67 RhuDex ® 67 eltrombopag 67 glufosfamide 67 Targretin 67 CINQUIL 67 L MTP PE 67 Telatinib 67 docetaxel chemotherapy 67 gemcitabine carboplatin 67 Genz # 67 AEGR 67 herpetic keratitis 67 Romidepsin 67 docetaxel Taxotere 67 SUPPRELIN R LA 67 T Pred 67 oral Xeloda 67 lomitapide 67 bicifadine 67 Aplidin 67 Omnitarg 67 refractory metastatic colorectal cancer 67 HRPC 67 evaluating mipomersen 67 Capesaris 67 CUSTOM III 67 NSABP C 67 carboplatin paclitaxel 67 DDP# 67 Phase III ADT 67 VISICOL R 67 MEND CABG II 67 Randomized Phase 67 ADAGIO study 67 TRISENOX ® 67 AZILECT ® 67 Mepact 67 Phase IIB 67 SANVAR 67 TMC# [002] 67 targeted radiotherapeutic 67 SPIRIT FIRST 67 Teysuno 67 QNEXA 67 NVA# 67 Taxotere docetaxel 67 metastatic GIST 67 VEGFR2 inhibitor 67 intravesical infusion therapy 67 inhaled formulation 67 LymphoStat B 67 FOLOTYN 67 Augment Injectable 67 Frova ® 67 DOXIL 67 Omacetaxine 67 Prostate AdenoCarcinoma Treatment 67 ONCONASE 67 adalimumab Humira 67 Phase III pivotal 67 ILLUMINATE 67 reduce serum phosphate 67 cutaneous T cell 67 FROVA 67 Alocrest 67 refractory gout 67 Brentuximab Vedotin SGN 67 bevirimat Study 67 MyVax personalized immunotherapy 67 multi kinase inhibitor 67 MOZOBIL 67 MGd 67 celgosivir 67 bortezomib Velcade R 67 pain palliation 67 HCV protease inhibitor 67 LEUKINE 67 Fludara 67 Phase IIb Trial 67 Gliadel Wafer 67 Icatibant 67 non metastatic osteosarcoma 67 PEG PAL 67 CCX# B 67 AVADO 67 FIRMAGON R 67 Virulizin R 67 pan histone deacetylase 67 nab paclitaxel 67 Camptosar ® 67 iniparib 67 Meets Primary Endpoint 67 faropenem 67 cutaneous T 67 SPARLON 67 palifosfamide 67 PrevOnco ™ 67 IV Busulfex 67 pediatric acute lymphoblastic 67 Phase #b/#a 67 Onrigin TM 67 EndoTAG TM -1 67 infusional 5-FU/LV 67 TASKi2 67 PEG interferon 67 pseudobulbar affect PBA 67 intranasal formulation 67 KNS # 67 SinuNase 67 IMPACT IMmunotherapy 67 Phase 1b dose escalation 67 Pegloticase 67 dosing cohorts 66 QuadraSphere 66 tenofovir emtricitabine 66 systemic ALCL 66 Study GL# 66 Phase Ia 66 recurrent glioblastoma 66 oral picoplatin 66 Biologics License Application BLA 66 Canvaxin 66 Dacogen decitabine 66 BrachySil TM 66 Ambrisentan 66 iclaprim 66 EchoCRT 66 Peg IFN 66 Hepatocellular Carcinoma HCC 66 OvaRex 66 confirmatory Phase 3 66 topically applied SEPA 66 pegylated interferon alfa 2a 66 LibiGel ® 66 chronic angina 66 #I TM# 66 Plicera 66 Tyrima 66 corticosteroid dexamethasone 66 bevacizumab Avastin 66 OvaRex R 66 CHAMPION PCI 66 PXD# 66 amrubicin 66 CIP TRAMADOL ER 66 alemtuzumab Campath 66 R#/MEM # 66 Iluvien ® 66 AQ4N 66 VNP#M 66 receptor tyrosine kinase inhibitor 66 ALN PCS 66 cetuximab Erbitux ® 66 Tesetaxel 66 adecatumumab MT# 66 indolent follicular non 66 diarrhea predominant irritable 66 ALN VSP Phase 66 RSR# 66 ILUVIEN ® 66 Neulasta ® 66 CALGB # [002] 66 resminostat 66 mCRC patients 66 CINTREDEKIN BESUDOTOX 66 DAVANAT 66 crizotinib PF # 66 pralatrexate 66 Octreolin 66 Myocet 66 anidulafungin 66 Zenvia TM 66 ARIMIDEX 66 Argatroban 66 INC# 66 ROTATEQ 66 Phase IIa clinical 66 ADVEXIN p# therapy 66 Silodosin 66 ACAPODENE TM 66 Intravenous CP 66 Pradefovir 66 Ozarelix 66 GRN# 66 entinostat 66 SNT-MC#/idebenone 66 BEXXAR 66 EDEMA4 66 Hycamtin ® 66 cilengitide 66 PF # [002] 66 maribavir 66 Lucanix R 66 FOLFIRI chemotherapy 66 human IgG1 monoclonal 66 Pirfenidone 66 MNTX 66 thetreatment 66 RhuDex TM 66 Romiplostim 66 arsenic trioxide injection 66 relapsing remitting MS RRMS 66 oral talactoferrin 66 vapreotide acetate 66 leading oral taxane 66 plus gemcitabine 66 MAXY alpha 66 investigational oral hepatitis C 66 prostate cancer HRPC 66 pharmacokinetic equivalence 66 Femara letrozole 66 CEQ# 66 systemic immunosuppressive drugs 66 arzoxifene 66 Chemophase 66 PEGylated interferon beta 1a 66 markets HP Acthar 66 Sular formulation 66 placebo controlled clinical 66 ezogabine 66 sapropterin dihydrochloride Tablets 66 Abiraterone acetate 66 Cleviprex TM clevidipine 66 plus dexamethasone 66 PRADAXA 66 topical gel containing 66 TAXOTERE ® 66 dacarbazine 66 SUTENT ® 66 Zolinza 66 ONTAK 66 Trofex 66 CCR5 mAb 66 aleglitazar 66 mg kg BID 66 Tavocept 66 varespladib 66 telaprevir VX 66 subcutaneous formulation 66 REOLYSIN ® 66 Stedivaze 66 gemcitabine chemotherapy 66 bazedoxifene 66 randomized Phase 2b 66 Initiate Clinical Trial 66 BrachySil 66 evaluating Nexavar 66 MKC# MT 66 Proquin XR 66 G#DT 66 cariprazine 66 Firazyr 66 5 fluorouracil leucovorin 66 BARACLUDE R 66 abacavir lamivudine 66 methylnaltrexone 66 MEK Inhibitor 66 Navelbine ® 66 ZADAXIN ® 66 Completes Patient Enrollment 66 SIR Spheres 66 rALLy 66 cediranib 66 Pegasys ® 66 Oracea TM 66 immunotherapeutic vaccine 66 sublingual tablets 66 Initiates Enrollment 66 UVIDEM 66 mTOR inhibitor 66 ribavirin RBV 66 SILENOR 66 TNFerade TM 66 Taxotere R 66 Randomized Phase II 66 Evoltra ® 66 Ceflatonin ® 66 delivers fluocinolone acetonide FA 66 Temsirolimus 66 KRAS mutations occur 66 lymphoma CTCL 66 WILEX 66 Xeloda capecitabine 66 Vidaza azacitidine 66 fostamatinib 66 ISENTRESS 66 THALOMID 66 ONGLYZA ™ 66 PTK ZK 66 μg dose 66 OHR/AVR# 66 Phase 2b trial 66 ocrelizumab 66 trabectedin 66 Soliris TM eculizumab 66 PEG Interferon lambda 66 FOLFOX4 66 Tarvacin TM 66 metastatic renal cell 66 sapacitabine 66 rNAPc2 66 dexanabinol 66 EndoTAGTM 1 66 fosbretabulin 66 Xyfid TM 66 TASKi3 66 sodium Injection 66 Zevalin R Ibritumomab 66 paclitaxel poliglumex 66 Onco TCS 66 R# #mg BID 66 pegylated interferon peg IFN 66 Pafuramidine 66 DPX Survivac 66 Zingo TM 66 platinum refractory 66 Neulasta R 66 atacicept 66 Dyloject TM 66 FUSILEV ® 66 Leukine 66 Triapine R 66 cystinosis patients 66 Vicriviroc 66 registrational Phase 66 albiglutide 66 TREANDA 66 CERVARIX 66 ribavirin therapy 66 Phase III Pivotal 66 capecitabine Xeloda R 66 satraplatin Phase 66 Diabetic Macular Edema 66 COPEGUS 66 SAR# [004] 66 R Saizen R 66 nitazoxanide 66 FavId 66 Taxotere ® 66 abiraterone acetate 66 cinacalcet HCl 66 evaluating picoplatin 66 Perforomist ™ Inhalation Solution 66 HGS ETR1 mapatumumab 66 lorvotuzumab mertansine 66 sargramostim 66 histone deacetylase HDAC inhibitor 66 fluoropyrimidine 66 Initiated Phase 66 Azedra TM 66 q8h 66 MyVax ® 66 Rebif ® 66 pomalidomide 66 evaluating REVLIMID 65 anthracyclines taxanes 65 AZILECT R 65 REBETOL combination therapy 65 BYETTA ® 65 Phase #/#a 65 Copegus ® 65 hoFH 65 dalbavancin 65 GRAVITAS trial 65 LibiGel Phase III 65 Zenpep 65 posaconazole 65 Aptivus 65 farletuzumab 65 pegylated interferon alpha 2a 65 GEM OS2 65 ofatumumab 65 mitoxantrone plus 65 Manja Bouman CEO 65 Sym# 65 LCP Tacro ™ 65 CA9 SCAN 65 clevidipine 65 EXPAREL TM 65 samalizumab 65 Pimavanserin 65 Arimidex anastrozole 65 Q#IR 65 personalized immunotherapy 65 plus prednisone prednisolone 65 AAG geldanamycin analog 65 Pegasys peginterferon alfa 2a 65 relapsed myeloma 65 esophageal candidiasis 65 picoplatin 65 PROSTVAC ® 65 CAPHOSOL 65 VALSTAR TM 65 Telavancin 65 trastuzumab Herceptin ® 65 humanised monoclonal antibody 65 PRIMO CABG 65 depsipeptide 65 MIST II 65 Certican 65 TroVax ® 65 Orathecin 65 MYDICAR 65 JZP 65 COLAZAL R 65 initiated Phase Ib 65 Maximum Tolerated Dose MTD 65 Initiates Phase II 65 liprotamase 65 TAXUS Element Stent System 65 JOULFERON 65 maximally tolerated dose 65 GVAX ® 65 CCR5 antagonist 65 NXL# 65 lucinactant 65 leukemia AML 65 Ophena 65 Mitoxantrone 65 nasal calcitonin product 65 Phase 2a 65 RIGScan CR 65 XL# anticancer compounds 65 Pennsaid R 65 Erbitux cetuximab 65 PhosLo 65 Pivotal Trial 65 TEMODAL 65 ZK EPO 65 immunotherapeutic agent 65 Androxal TM 65 myelodysplastic myeloproliferative diseases 65 personalized cellular immunotherapy 65 dose escalation 65 ALGRX 65 AMEVIVE 65 DexaSite 65 Diamyd ® 65 Clevudine 65 dependent kinase inhibitor 65 BR.# 65 recurrent malignant glioma 65 Marketing Authorisation Application 65 ZD# [001] 65 investigational humanized monoclonal antibody 65 hormone LHRH antagonist 65 Campath ® 65 opioid induced constipation OIC 65 Phase III randomized controlled 65 Phase 2b kidney transplant 65 acetonide FA 65 AZOR 65 Phase IIb trial 65 pegfilgrastim 65 Entereg R 65 REVLIMID ® 65 ZEVALIN ® 65 Phase Ib clinical trials 65 Fx #A 65 platelet inhibitor 65 Kepivance 65 huN# DM1 65 SUTENT 65 cell carcinoma RCC 65 concurrent chemoradiation 65 ARCALYST ® 65 REG1 Anticoagulation System 65 protease inhibitor PI 65 Phase III Clinical Trial 65 faropenem medoxomil 65 PEGylated interferon 65 Taxotere chemotherapy 65 Xcellerated T Cells 65 goserelin 65 bortezomib Velcade 65 Zytiga 65 REVLIMID R 65 Oral NKTR 65 evaluating Xcytrin 65 MoxDuo IR 65 Votrient 65 initiate Phase IIb 65 IMPACT DCM 65 visilizumab 65 Elagolix 65 OncoVex 65 Phase III HEAT 65 azacitidine 65 investigational HCV polymerase 65 Xcytrin R 65 monoclonal antibody conjugated 65 naïve HCV 65 ENDEAVOR IV 65 IRESSA 65 miconazole Lauriad ® 65 Canvaxin TM 65 MabThera Rituxan 65 PEG IFN 65 riociguat 65 Phase IIIb study 65 prGCD 65 Panitumumab 65 TPI ASM8 65 peginterferon alfa 2b 65 Azixa 65 de novo kidney transplant 65 Vascular Disrupting Agent 65 Raptiva r 65 efaproxiral 65 histamine dihydrochloride 65 cisplatin gemcitabine 65 Besivance 65 anthracycline taxane 65 Microplasmin 65 mifamurtide 65 ALN HPN 65 MEND CABG 65 relapsing multiple sclerosis 65 IND submission 65 Orazol 65 Crofelemer budesonide foam 65 pazopanib 65 NDA Submission 65 #mg dose [002] 65 Campath alemtuzumab 65 Sprycel dasatinib 65 OMAPRO ™ 65 ProSavin 65 Xerecept 65 corticotropin injection 65 Sapacitabine 65 remission induction 65 ritonavir boosted 65 im peramivir